Literature DB >> 2957490

Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues.

K L Cole, G J Seymour, R N Powell.   

Abstract

T-cell subsets extracted from chronically inflamed periodontal tissues were identified using monoclonal antibodies, and their functional activity was analysed using the autologous mixed lymphocyte reaction (AMLR). Tissue was obtained from a total of 33 adult periodontitis (AP) patients and 6 normal/marginal gingivitis (N/MG) patients. All AP patients had received repeated oral hygiene instruction and root planing prior to the surgery, and the majority (30 out of 33) had at least one site with greater than 6 mm loss of attachment from the cementoenamel junction within the surgical field. The N/MG patients had no loss of attachment, and probing depths were less than 3 mm. Single cell suspensions were obtained following collagenase digestion (90 minutes at 37 degrees C) and mechanical disruption of the tissue. T-cell subsets were identified using an indirect immunofluorescence assay on cells obtained from 19 AP patients and the 6 N/MG patients. The mean (+/- standard error) helper:suppressor (T4:T8) ratio for the AP patients was found to be 0.94 +/- 0.48 compared with 1.65 +/- 0.16 for the N/MG group and 1.51 +/- 0.12 for peripheral blood controls. HLA-DR positive macrophages were identified and were found to include both acid phosphatase (AcP) positive and adenosine triphosphatase (ATPase) positive populations. Functional analysis was carried out using cells extracted from the remaining 14 AP patients. Cells from six of these 14 patients were found to be capable of spontaneous proliferation. Co-culture experiments using autologous T and non-T populations revealed that cells from only four patients were able to respond in an AMLR while those from only one of the 14 patients were able to stimulate the AMLR.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 2957490     DOI: 10.1902/jop.1987.58.8.569

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  8 in total

Review 1.  Inflammatory and immune pathways in the pathogenesis of periodontal disease.

Authors:  Ali Cekici; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  Periodontol 2000       Date:  2014-02       Impact factor: 7.589

2.  Immunohistological analysis of experimental gingivitis in humans.

Authors:  G J Seymour; E Gemmell; L J Walsh; R N Powell
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

3.  Elevated proportion of natural killer T cells in periodontitis lesions: a common feature of chronic inflammatory diseases.

Authors:  K Yamazaki; Y Ohsawa; H Yoshie
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  Modulation of gamma interferon-induced major histocompatibility complex class II gene expression by Porphyromonas gingivalis membrane vesicles.

Authors:  Ratchapin Srisatjaluk; Girish J Kotwal; Lawrence A Hunt; David E Justus
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Selective expansion of T cells in gingival lesions of patients with chronic inflammatory periodontal disease.

Authors:  K Yamazaki; T Nakajima; Y Ohsawa; K Tabeta; H Yoshie; K Sakurai; G J Seymour
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

6.  Cloning, characterization, and antigen specificity of T-lymphocyte subsets extracted from gingival tissue of chronic adult periodontitis patients.

Authors:  A Wassenaar; C Reinhardus; T Thepen; L Abraham-Inpijn; F Kievits
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 7.  Roles of Porphyromonas gingivalis and its virulence factors in periodontitis.

Authors:  Weizhe Xu; Wei Zhou; Huizhi Wang; Shuang Liang
Journal:  Adv Protein Chem Struct Biol       Date:  2020-01-10       Impact factor: 3.507

8.  Immunohistological analysis of T cell functional subsets in chronic inflammatory periodontal disease.

Authors:  K Yamazaki; T Nakajima; K Hara
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.